A review on recent advances in drugs for lung cancer treatment

A review on recent advances in drugs for lung cancer treatment

This thesis is submitted in partial fulfillment of the requirements for the degree of Bachelor of Pharmacy, 2023.

Détails bibliographiques
Auteur principal:	Noor, Fouzia
Autres auteurs:	Akter, Raushanara
Format:	Thèse
Langue:	English
Publié:	Brac University 2024
Sujets:	Lung cancer Recent advances Drugs Resistance Mechanism of action Lung cancer > Treatment
Accès en ligne:	http://hdl.handle.net/10361/22049

Documents similaires

Potential of liposomes for the treatment of lung cancer- a review
par: Mim, Shanzida
Publié: (2023)

A review on targeted therapies for lung cancer
par: Ashraf, Anushey
Publié: (2023)

Molecules associated with the development of lung cancer
par: Rahman, Adree, et autres
Publié: (2023)

Impact of treatment size and therapy type in phase II clinical trials of non-small cell lung cancer
par: Rahman, Tasnim
Publié: (2024)

Protein biomarkers for Lung Cancer: a bioinformatic approach
par: Jeba, Joynob
Publié: (2017)

Recent developments in the Adeno-Associated Viral Gene Therapy for Non-Small Cell Lung Cancer during the past 20 years
par: Razna, Amrin Islam
Publié: (2019)

Immunotherapy in the Management of Lung Cancer
par: Tasnim, Humayra
Publié: (2022)

A cross-sectional study on risk factors, symptoms, treatment and management strategies of lung cancer in a tertiary care cancer hospital of Bangladesh
par: Pial, Sazia Afrin
Publié: (2018)

Computational insights into molecular docking strategies for non-small cell lung cancer drug discovery
par: Das, Reshita
Publié: (2024)

Targeted treatment in patients with non-small cell lung cancer: Use of Bevacizumab and its Biosimilars
par: Tania, Umme
Publié: (2023)

Bioinformatics analyses of key regulators of NF-κB pathway in relation with small cell lung carcinoma
par: Zangmo, Thinley
Publié: (2024)

Efficacy analysis and prediction in phase II clinical trials of non-small cell Lung Cancer
par: Hoque, Ismoth Ara
Publié: (2024)

Efficacy analysis of tyrosine kinase inhibitor combinations in phase II clinical trials of non-small cell lung cancer
par: Flora, Sanzida Alam
Publié: (2024)

A case study of lung cancer patients in term of various risk factors in context of Bangladesh
par: Shabnam, Musharrat
Publié: (2018)

Effect of performance status on efficacy endpoints in phase II trials of non-small cell lung cancer
par: Paul, Pulock
Publié: (2024)

An overview of the clinical management and challenges of treatments for the patients diagnosed with COVID-19 and lung carcinoma
par: Bristy, Israt Zerin
Publié: (2021)

Current practice and approaches of immunotherapy in Cancer treatment
par: Khondokar, Faiza
Publié: (2022)

A comprehensive review on drug repurposing in cancer treatment
par: Sarkar, Onusree
Publié: (2024)

A review of Breast Cancer risk factor assessment on women in developing countries, cancer drug resistance, and Breast Cancer treatment in Bangladesh
par: Raihan, Dilraj
Publié: (2024)

Lung cancer detection and classification using machine learning
par: Arefin, Mahbubul, et autres
Publié: (2023)

Lung cancer immunosuppression and therapeutic targeting of myeloid- derived suppressor cells
par: Nandy, Aditi
Publié: (2022)

Recent advancement on breast cancer detection and treatment
par: Rahman, Sanjida
Publié: (2023)

Drug repurposing: potential of Antimicrobial Drugs in Breast Cancer Treatment
par: Chakraborty, Anuradha
Publié: (2024)

RIPK pathway, as a potential target, for cancer treatment - a review
par: Jahan, Nusrat
Publié: (2024)

A review on nanoparticles based drug delivery in cancer treatment: advantages & challenges
par: Nahar, Kamrun
Publié: (2023)

Score based risk assessment of lung cancer and its evaluation for Bangladeshi people
par: Mukti, Roushney Fatima, et autres
Publié: (2016)

Identification of the multi-drug resistant genes in the bacteria isolated from the saliva of smoker oral cancer patients and comparative analysis with smoker normal individuals
par: Hasan, Samir, et autres
Publié: (2024)

Natural products and their combinatory effects in breast cancer treatment
par: Siddique, Md. Ayman
Publié: (2021)

Precision medicine in four deadliest Cancers of the world : present practices & future prospects
par: Islam, Ankita
Publié: (2022)

A review on the recent advancements on nanoparticles drug delivery approaches in anti-cancer treatment
par: Hoque, Syeda Mehren
Publié: (2024)

Microneedles in pain management of Cancer
par: Islam, Shafiqul
Publié: (2022)

Breast cancer therapy through Liposomal drug delivery system
par: Ome, Nusrat Jahan
Publié: (2024)

Evaluation of genetics of cancer predisposition in patients and efficacy of various chemotherapeutic drugs in Bangladesh
par: Hossain, Safa Binte
Publié: (2019)

Potential phytochemicals and dietary components for the prevention and treatment of skin cancer: A review
par: Muntaha, Habibatul
Publié: (2023)

Pooled analysis of response rate and overall survival of Tyrosine Kinase inhibitor combinations in phase II clinical trials of non-small cell lung cancer
par: Karim, Samia Binte
Publié: (2024)

Biosimilar in lymphoma treatment
par: Tanisha, Mehrin Haque
Publié: (2021)

Therapeutic prospective of targeting calcium homeostasis in cancer – a review
par: Kamal, Tasnova
Publié: (2019)

A review on carbon nanotube: a new era in cancer diagnosis & therapy
par: Parvez, Safi
Publié: (2023)

The impact of cell penetrating peptides in prospective cancer therapy: a review
par: Nashrah, Zannatul
Publié: (2023)

Palliative care services in cancer treatment: a study of the current scenario in Dhaka
par: Rahman, Qazi Ashrafur
Publié: (2018)